Analysen von Richard Vosser
| 09:31 | Sartorius vz. Overweight | JP Morgan Chase & Co. | |
| 16.03.26 | Merck Overweight | JP Morgan Chase & Co. | |
| 09.03.26 | Bayer Overweight | JP Morgan Chase & Co. | |
| 05.03.26 | arGEN-X Overweight | JP Morgan Chase & Co. | |
| 05.03.26 | Merck Overweight | JP Morgan Chase & Co. | |
| 04.03.26 | Bayer Overweight | JP Morgan Chase & Co. | |
| 04.03.26 | Bayer Overweight | JP Morgan Chase & Co. | |
| 02.03.26 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
|
Werbung
|
|||
| 23.02.26 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 23.02.26 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 18.02.26 | Bayer Overweight | JP Morgan Chase & Co. | |
| 18.02.26 | Bayer Overweight | JP Morgan Chase & Co. | |
| 12.02.26 | Novartis Overweight | JP Morgan Chase & Co. | |
| 11.02.26 | Sartorius vz. Overweight | JP Morgan Chase & Co. | |
| 10.02.26 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 09.02.26 | Merck Overweight | JP Morgan Chase & Co. | |
| 06.02.26 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 06.02.26 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 05.02.26 | Bayer Overweight | JP Morgan Chase & Co. | |
| 04.02.26 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 02.02.26 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 02.02.26 | Bayer Overweight | JP Morgan Chase & Co. | |
| 30.01.26 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 28.01.26 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 23.01.26 | Bayer Overweight | JP Morgan Chase & Co. | |
| 19.01.26 | Merck Overweight | JP Morgan Chase & Co. | |
| 19.01.26 | Bayer Overweight | JP Morgan Chase & Co. | |
| 16.01.26 | Merck Overweight | JP Morgan Chase & Co. | |
| 15.01.26 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 15.01.26 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 06.01.26 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 05.01.26 | Novartis Overweight | JP Morgan Chase & Co. | |
| 05.01.26 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 23.12.25 | Novartis Overweight | JP Morgan Chase & Co. | |
| 18.12.25 | Merck Overweight | JP Morgan Chase & Co. | |
| 16.12.25 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 15.12.25 | Merck Overweight | JP Morgan Chase & Co. | |
| 15.12.25 | arGEN-X Overweight | JP Morgan Chase & Co. | |
| 15.12.25 | Sartorius Stedim Biotech Overweight | JP Morgan Chase & Co. | |
| 15.12.25 | Sartorius vz. Overweight | JP Morgan Chase & Co. | |
| 08.12.25 | Sartorius Stedim Biotech Overweight | JP Morgan Chase & Co. | |
| 08.12.25 | Sartorius vz. Overweight | JP Morgan Chase & Co. | |
| 08.12.25 | Merck Overweight | JP Morgan Chase & Co. | |
| 08.12.25 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 08.12.25 | Bayer Overweight | JP Morgan Chase & Co. | |
| 08.12.25 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 08.12.25 | Novartis Overweight | JP Morgan Chase & Co. | |
| 25.11.25 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 24.11.25 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 14.11.25 | Merck Overweight | JP Morgan Chase & Co. | |